Immediate Impact
6 standout
Citing Papers
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
2023 Standout
EASL recommendations on treatment of hepatitis C: Final update of the series☆
2020 Standout
Works of G. W. Sullivan being referenced
Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. W. Sullivan | 43 | 31 | 7 | 36 | 10 | 113 | |
| Noah Warner | 69 | 21 | 14 | 16 | 8 | 102 | |
| Zhi Zou | 211 | 140 | 2 | 16 | 14 | 235 | |
| Qiming Lu | 27 | 71 | 8 | 9 | 110 | ||
| Robert D. Seeley | 43 | 44 | 47 | 13 | 161 | ||
| Junjie Shi | 24 | 40 | 12 | 136 | |||
| Daan Martens | 141 | 78 | 14 | 193 | |||
| S. Kitagawa | 30 | 3 | 30 | 3 | 13 | 102 | |
| Jakob Jonnerby | 24 | 61 | 7 | 8 | 120 | ||
| W.G. Heyes | 3 | 40 | 4 | 16 | 96 | ||
| Yufeng Li | 8 | 21 | 2 | 12 | 107 |
All Works
Login with ORCID to disown or claim papers
Loading papers...